Cue Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,517
Closed -$580K 49
2018
Q3
$580K Sell
7,517
-105
-1% -$7.93K 0.35% 101
2018
Q2
$540K Sell
7,622
-459
-6% -$32.4K 0.33% 108
2018
Q1
$609K Buy
8,081
+150
+2% +$11.9K 0.4% 95
2017
Q4
$568K Sell
7,931
-140
-2% -$10.6K 0.37% 94
2017
Q3
$654K Buy
+8,071
New +$617K 0.45% 83
2016
Q4
Sell
-9,241
Closed -$731K 160
2016
Q3
$731K Buy
9,241
+17
+0.2% +$1.38K 0.62% 60
2016
Q2
$769K Sell
9,224
-705
-7% -$62.6K 0.66% 61
2016
Q1
$912K Buy
9,929
+2,420
+32% +$218K 0.79% 47
2015
Q4
$760K Buy
7,509
+200
+3% +$20.8K 0.68% 58
2015
Q3
$718K Buy
7,309
+588
+9% +$65.3K 0.75% 56
2015
Q2
$787K Buy
6,721
+555
+9% +$60.6K 0.74% 55
2015
Q1
$600K Buy
6,166
+268
+5% +$27.2K 0.6% 72
2014
Q4
$556K Buy
+5,898
New +$610K 0.58% 75

Other funds holding GILD

Cue Advisory Services's GILD Position: Q4 2018 in Review

Cue Advisory Services sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 7,517 shares — an estimated $580K sold.

Cue Advisory Services first reported a position in GILD in Q4 2014 and held it in 13 quarters. The position peaked at $912K in Q1 2016. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Cue Advisory Services reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Cue Advisory Services sold 7,517 Gilead Sciences shares in Q4 2018, an estimated $580K.
  • Cue Advisory Services first reported a position in Gilead Sciences in Q4 2014 and held it in 13 quarters.
  • Cue Advisory Services's Gilead Sciences position peaked at $912K in Q1 2016.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Cue Advisory Services's 13F filing for Q4 2018.